Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000075 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
30,000
Total Value
$1,223,487.79
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 8,542 | $12.50 | $106,775.00 | 23,854 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 1,458 | $34.39 | $50,140.62 | 25,312 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Sale | 2,100 | $104.67 | $219,814.14 | 23,212 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Sale | 2,132 | $105.57 | $225,078.65 | 21,080 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Sale | 1,268 | $106.63 | $135,201.13 | 19,812 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Sale | 2,142 | $107.71 | $230,722.96 | 17,670 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Aug 13, 2026 | Sale | 2,358 | $108.46 | $255,755.28 | 15,312 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 8,542 | $0.00 | $0.00 | 92,917 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 1,458 | $0.00 | $0.00 | 59,792 | Direct | โ | View Details |